目的对肺炎支原体感染的患儿实施个体化的干预措施,以提高临床疗效及减少不良反应发生率,进一步探讨在肺炎支原体感染中的价值。方法将2012年9月一2013年8月医院收治100例肺炎支原体感染患儿随机分为干预组和对照组,每组各50例;两组患儿在入院后均采用常规的抗菌药物,以及止咳化痰药物作为辅助治疗药物;干预组除了采用常规护理外,另给予个体化干预措施,对照组仅给予常规护理措施,对两组患儿的疗效和不良反应进行比较,采用SPSS16.0进行分析。结果总有效率、不良反应发生率对照组分别为62.00%和26.00%,干预组分别为92.00%和10.00%,两组的总有效率和不良反应发生率比较差异均有统计学意义(P〈0.05)。结论对肺炎支原体感染的患儿实施个体化干预措施,不仅可以明显提高肺炎支原体感染的治疗效果,而且可以减少肺炎支原体感染不良反应的发生率,促使患儿康复。
OBJECTIVE To implement individualized intervention measures in children with Mycoplasma pneumoniae infection so as to increase clinical efficacy and reduce incidence of adverse reactions and further explore the value of individualized intervention for M. pneumonia infection. METHODS Totally 100 children with M. pneumoniae infection admitted in the hospital during Spet. 2012 to Aug. 2013 were randomly divided into two groups, with 50 children in each group. All children were treated with conventional antibiotics and agents for relieving cough and reducing sputum as the adjuvant medication. Moreover, patients in the intervention group were given with individ- ualized nursing care in addition to routine nursing, while patients in the control group received only routine nursing. The efficacy and adverse reactions were compared between the two groups, and analyzed with SPSS 16.0. RESULTS The total effective rate and the incidence of adverse reactions were 62.00%, 26.00% in the control group and 92.00%, 10.00% in the intervention groups, with significant differences (P〈0.05). CONCLUSION Individualized nursing measures for M. pneumoniae infection can improve therapeutic efficacy, reduce adverse reactions and promote recovery in children with M. pneumonia.